Pfizer hike list price of 41 medicines

Pfizer to hike list price of 41 medicines


Pfizer has announced that it plans to increase the list price of 41 medicines, or 10% of its entire drug portfolio, as of January 15. The company indicated that “the increase in list price to this subset of [our] portfolio will be 5%,” with the only exceptions being three drugs, which will see their prices rise 3%, and one other product, whose cost will jump 9%. List prices for the remainder of the portfolio will be unchanged, the drugmaker said.

Read full article here: as written by Joe Barber

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.